Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd.
9
Recruiting trials
10
Conditions studied
Phase breakdown
Phase 2 2Phase 3 6Not applicable 3
Conditions studied
Recruiting trials led by Otsuka Pharmaceutical Co., Ltd.
- A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
- A Long-term Trial of EB-1020 in Adult Patients With ADHD
- A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
- A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
- Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
- LUPKYNIS Drug-use Results Survey
- REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)
- Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
- Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Common questions
How many trials is Otsuka Pharmaceutical Co., Ltd. recruiting for?
Otsuka Pharmaceutical Co., Ltd. is the lead sponsor of 9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.